INVESTOR ALERT: Law Offices of Howard G. Smith Announces An Expanded Class Period In The Class Action Lawsuit Against Regado Biosciences, Inc.

Law Offices of Howard G. Smith announces that the shareholder lawsuit filed on behalf of investors of Regado Biosciences, Inc. (“Regado” or the “Company”) (NASDAQ:RGDO) has been expanded to include all purchasers of Regado securities between August 22, 2013 and July 9, 2014, inclusive (the “Class Period”), including purchasers pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company’s initial public offering on or about August 21, 2013.

Regado is a biopharmaceutical company, focused on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular indications. The Company’s product candidate, Revolixys™ Kit, is an anticoagulant for use in patients with acute coronary syndromes. The Complaint alleges that defendants made false and misleading statements or failed to disclose that: (1) the administration of Revolixys presented a significant risk of severe allergic reaction, which substantially undermined Revolixys’ potential to become the new standard of care for anticoagulation therapy for patients undergoing cardiovascular procedures, and (2) the Company’s positive statements about Revolixys’ clinical development and potential to become the standard of care for anticoagulation therapy were materially false and misleading or lacked a reasonable basis.

On August 25, 2014, Regado announced that the Company decided to permanently terminate enrollment in the Company's Phase 3 trial of Revolixys, based on a recommendation from the trial’s Data Safety Monitoring Board that “the level of serious allergic adverse events associated with Revolixys was of a frequency and severity such that they recommended that we do not enroll any further patients.” Following this news, the price of Regado shares dropped as much as 58%, or $1.69 per share, on August 25, 2014.

If you are a member of the Class described above, you may move the Court no later than September 8, 2014, to serve as lead plaintiff, if you meet certain legal requirements. To be a member of the Class, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Contacts:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.